US Broker Ratings

Eli Lilly and Company (LLY) Stock Analysis: Gauging a 29.5% Potential Upside Amidst Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY) stands as a formidable player in the healthcare sector, specifically in the general drug manufacturing industry. With a market capitalization of $662.23 billion, Eli..

McKesson Corporation (MCK) Stock Analysis: Navigating a Strong Growth Trajectory Amidst Healthcare Demand

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, has captured investor attention with its robust market presence and strategic operations. As a leader in medical distribution, McKesson is..

UnitedHealth Group (UNH) Stock Analysis: A 30.95% Potential Upside Awaits Investors

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, stands as a beacon of opportunity for investors seeking a robust player in the health care plans industry. With..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating a 40% Upside Potential with Industry-Leading Innovations

Thermo Fisher Scientific Inc (NYSE: TMO), a prominent leader in the healthcare sector, is capturing the attention of investors with a compelling upside potential of 40.56%. This Massachusetts-based giant, known..

Cardinal Health, Inc. (CAH) Stock Analysis: Unpacking Its Modest Potential Upside Amidst a Robust Market Presence

Cardinal Health, Inc. (NYSE: CAH), a formidable player in the healthcare sector, stands as a testament to the dynamic nature of the medical distribution industry. With a market capitalization of..

Danaher Corporation (DHR) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Giant

Danaher Corporation (NYSE: DHR), a formidable player in the healthcare sector, specifically in diagnostics and research, presents a compelling opportunity for investors seeking growth potential in their portfolios. With a..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

ResMed Inc. (RMD) Stock Analysis: Evaluating Its 8% Upside Potential Amid Healthcare Innovations

ResMed Inc. (NYSE: RMD), a leader in the healthcare sector, has long been a beacon for investors interested in medical instruments and supplies. With a market capitalization of $35.89 billion,..

Gilead Sciences, Inc. (GILD) Stock Analysis: Attractive Dividend Yield Amid Modest Growth Prospects

Gilead Sciences, Inc. (NASDAQ: GILD), a heavyweight in the biopharmaceutical industry, is capturing the attention of investors with its robust market presence and a compelling dividend yield of 2.87%. Despite..

Boston Scientific Corporation (BSX) Stock Analysis: A Healthcare Giant with 11.12% Upside Potential

Boston Scientific Corporation (NYSE: BSX), a prominent player in the medical devices industry, continues to capture the attention of investors with its solid market performance and growth potential. With a..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Unpacking a $197 Billion Healthcare Giant’s Growth Potential

Intuitive Surgical, Inc. (ISRG), a titan in the healthcare sector, has long been associated with pioneering advancements in medical instruments and supplies. Headquartered in Sunnyvale, California, the company has solidified..

Stryker Corporation (SYK) Stock Analysis: Navigating a 10% Upside in the Medical Device Sector

Stryker Corporation (NYSE: SYK), a formidable player in the healthcare sector and a leader in medical devices, stands as a beacon of innovation with a robust market cap of $146.23..

Merck & Company, Inc. (MRK) Investor Outlook: A Potential Upside of 32.47% Amidst Solid Dividend Yield

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, particularly in the drug manufacturing industry, continues to capture the attention of investors with its robust market presence..

Elevance Health, Inc. (ELV) Stock Analysis: Uncovering a 31% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare sector, is capturing investor attention with its robust market position and a compelling potential upside of 31.17%, based on..

Sanofi (SNY) Stock Analysis: A 32.72% Upside Potential with Strong Buy Ratings

Sanofi (SNY), a titan in the healthcare sector, is positioned as a compelling investment opportunity with a potential upside of 32.72%, according to analyst ratings. With its current stock price..

Novo Nordisk A/S (NVO) Stock Analysis: Assessing a 28% Upside Potential in the Healthcare Giant

Novo Nordisk A/S (NVO), a dominant force in the healthcare sector, continues to capture the attention of investors with its strong market presence and promising growth prospects. Headquartered in Bagsvaerd,..

Abbott Laboratories (ABT) Stock Analysis: Evaluating Growth Potential with a 5.23% Upside

Abbott Laboratories (NYSE: ABT) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $232.41 billion, Abbott’s extensive product line..

PureTech Health plc (PRTC) Stock Analysis: Uncovering a 190% Upside in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, PureTech Health plc (PRTC) presents a compelling case with its significant potential upside of 190.03%, as suggested by analyst target prices. With..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a Promising 114.70% Upside in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, is capturing investor attention with a compelling potential upside of 114.70%, as indicated by recent analyst ratings. This Israel-based..

COMPASS Pathways (CMPS): Exploring a Potential 306% Upside in the Mental Health Revolution

COMPASS Pathways Plc (NASDAQ: CMPS) is carving a niche in the healthcare sector with its innovative approach to mental health treatment. As a biotechnology company based in the United Kingdom,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds